Testing a new malaria drug in healthy volunteers
Part of Infections clinical trials.
This trial tests a new malaria drug (MMV055), alone or with another drug (MMV371), to see if it is safe and how the body processes it. It is for healthy people who want to help find new malaria treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You are in good health, as determined by medical exams and blood tests.
- You have a body mass index (BMI) between 19 and 30, and weigh at least 45 kg (women) or 50 kg (men).
- You must agree to use reliable birth control during the study.
- You do not have any serious heart, liver, kidney, or lung conditions.
- You have not taken other investigational drugs in the last 90 days.
- You do not smoke or use nicotine products (like e-cigarettes) and haven't for the past 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug (GSK4425689A) for the first time in humans. It is a healthy volunteer study to check the safety, side effects, and how the drug moves through the body. It may help in the future development of treatments for malaria.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This study tests a genetically modified malaria parasite that is intentionally given to healthy volunteers through a mosquito bite. The goal is to see if it is safe and to learn how the immune system responds, which could help develop a malaria vaccine.
This study tests a new malaria vaccine in healthy adults. You will receive the vaccine and then be exposed to the malaria parasite in a controlled setting to check if the vaccine protects you.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
Hear when a new Malaria Falciparum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.